Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil

A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward…